Dr. Venditti is a Senior Investigator in the National Human Genome Research Institute and the Director of the Organic Acid Research Section at the National Institutes of Health in Bethesda, MD. As a metabolic pediatrician, he has developed a translational research program to study the natural history and clinical phenotype(s) of the hereditary methylmalonic acidemias (MMA), cobalamin metabolic disorders, and propionic acidemia (PA), grave conditions that mainly affect infants and children. His laboratory is developing gene, cell and small molecules therapeutics to treat MMA and PA. Dr Venditti has authored and co-authored more than 120 peer reviewed research articles, reviews, and textbook chapters and is the principle inventor of multilple US patents.